Filana Therapeutics, Inc. SEC filings FLNA
Filana Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 9, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | Dec 5, 2025 | — |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 424B2 | Prospectus | Jan 3, 2024 | — |
| 424B5 | Prospectus supplement | May 1, 2023 | — |
| S-3ASR | Automatic shelf registration | May 1, 2023 | — |
| 424B5 | Prospectus supplement | Nov 21, 2022 | — |
| 424B5 | Prospectus supplement | Jul 29, 2022 | — |
| S-8 | Employee stock plan registration | Jun 10, 2022 | — |
| 424B5 | Prospectus supplement | Feb 12, 2021 | — |
| S-3ASR | Automatic shelf registration | Feb 10, 2021 | — |
| 424B5 | Prospectus supplement | Nov 16, 2020 | — |
| FWP | Free writing prospectus | Nov 13, 2020 | — |
| 424B5 | Prospectus supplement | Nov 12, 2020 | — |
| 424B2 | Prospectus | May 5, 2020 | — |
| S-3/A | Filing | Apr 9, 2020 | — |
| S-3 | Shelf registration | Mar 27, 2020 | — |
| S-1 | Registration statement | Dec 18, 2018 | — |
| 424B5 | Prospectus supplement | Aug 17, 2018 | — |
| 424B3 | Prospectus | Aug 16, 2018 | — |
| S-8 | Employee stock plan registration | Jun 19, 2018 | — |
| 424B5 | Prospectus supplement | Feb 9, 2018 | — |
| S-3/A | Filing | Jul 27, 2017 | — |
| S-3 | Shelf registration | Apr 14, 2017 | — |
| 424B5 | Prospectus supplement | Dec 22, 2015 | — |
| S-3 | Shelf registration | Feb 5, 2014 | — |
| S-3/A | Amendment no. 2 to form s-3 | Aug 2, 2010 | — |
| S-8 | Employee stock plan registration | Jul 29, 2010 | — |
| S-3/A | Amendment no. 1 to form s-3 | May 3, 2010 | — |
| S-3 | Shelf registration | Feb 2, 2010 | — |
| S-8 | Employee stock plan registration | Jul 31, 2008 | — |
| S-8 | Employee stock plan registration | Nov 13, 2007 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FLNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1069530
- Former names
- CASSAVA SCIENCES INC (until Feb 19, 2026); PAIN THERAPEUTICS INC (until Mar 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.